Evidence map›Paper›PMID 39726973›Full record

ReviewCurrent research in microbial sciences2024

Gut microbiota and bile acids: Metabolic interactions and impacts on diabetic kidney disease.

Ping Liu, Meiping Jin, Ping Hu, Weiqian Sun, Yuyan Tang, Jiajun Wu, Dongliang Zhang, Licai Yang, Haidong He, Xudong Xu

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Current research in microbial sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Trial
  2. Review
  3. Review
  4. Review
  5. Peptide Hormones in Appetite Regulation: A Complex Network.Pharmaceuticals (Basel, Switzerland) · 2026
    Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Polysaccharides from the root tubers ofFrontiers in pharmacology · 2026
    Article
  13. New Insights into the Role of Mitochondrial Dysfunction in Diabetic Kidney Disease in the Omics Era.Diabetes, metabolic syndrome and obesity : targets and therapy · 2026
    Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Ping LiuDivision of Nephrology, Minhang Hospital, Fudan University, Shanghai, China.
Meiping JinDivision of Nephrology, Minhang Hospital, Fudan University, Shanghai, China.
Ping HuDivision of Nephrology, Minhang Hospital, Fudan University, Shanghai, China.
Weiqian SunDivision of Nephrology, Minhang Hospital, Fudan University, Shanghai, China.
Yuyan TangDivision of Nephrology, Minhang Hospital, Fudan University, Shanghai, China.
Jiajun WuDivision of Nephrology, Minhang Hospital, Fudan University, Shanghai, China.
Dongliang ZhangDivision of Nephrology, Minhang Hospital, Fudan University, Shanghai, China.
Licai YangDivision of Nephrology, Minhang Hospital, Fudan University, Shanghai, China.
Haidong HeDivision of Nephrology, Minhang Hospital, Fudan University, Shanghai, China.
Xudong XuDivision of Nephrology, Minhang Hospital, Fudan University, Shanghai, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The intestinal microbiota comprises approximately 10

Indexed as

Bile acidsDiabetic nephropathyFarnesoid receptorG protein-coupled receptorIntestinal flora

Identifiers

PMID39726973
PMCPMC11670419

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.